MedTech News
.................... by Andrew Celentano
Carbon-ion therapy offers nonsurgical option for early breast cancer treatment
For many women with early breast cancer, surgery is effective but life-altering. New five-year data from the National Institutes for Quantum Science and Technology (QST) suggest that a precisely targeted, high-energy particle therapy may allow some patients to avoid surgery without compromising oncologic outcomes.
How pancreatic tumors use the MYC protein to evade immune detection
An international research team has succeeded in deciphering a key mechanism that controls the growth of pancreatic cancers.
AI tool predicts cancer metastasis risk using gene expression signatures
Why do some tumors spread while others remain localized? The mechanisms governing the metastatic potential of tumor cells remain largely unknown—yet understanding this is crucial for optimizing patient care.
Skin imaging scan can detect early signs of heart disease
Researchers from Helmholtz Munich and the Technical University of Munich (TUM) have developed “fast-RSOM,” a new imaging technology that can capture detailed images of the smallest blood vessels directly through the skin—without the need for invasive procedures.
Aidoc Secures FDA Clearance for Healthcare’s First Comprehensive Foundation Model AI
11 newly cleared indications, combined with three existing ones, introduce an AI safety net for crowded Emergency Departments and imaging backlogs
First Peer-Reviewed Study Shows Tissue Once Deemed Non-Salvageable Can Be Healed in Patients Facing Amputation
BREA, Calif., Jan. 21, 2026 /PRNewswire/ — Rapid Nexus Nanotech Wound Solutions, Inc., a California-based medical technology company, today announced the publication of a peer-reviewed study documenting outcomes that challenge long-held assumptions about neuropathy-driven tissue damage and limb loss.
Machina Medical Receives FDA Clearance for MFUSE External Bleeding Control Device
MFUSE is designed to support clinicians in managing external bleeding by forming a flexible hydrogel barrier when applied to the wound site
SurGenTec gains new FDA indication for ION-C facet fixation system
SurGenTec’s ION-C system is now indicated for the treatment of cervical pseudoarthrosis when implanted bilaterally within the facet joints.